Last reviewed · How we verify
placebo pearls
Placebo pearls are inert, having no pharmacological effect.
Placebo pearls are inert, having no pharmacological effect. Used for Control in clinical trials.
At a glance
| Generic name | placebo pearls |
|---|---|
| Also known as | Placebo |
| Sponsor | Bambino Gesù Hospital and Research Institute |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
They are used as a control in clinical trials to compare the efficacy of active treatments. Placebo pearls do not interact with biological systems in any way.
Approved indications
- Control in clinical trials
Common side effects
Key clinical trials
- Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091) (PHASE3)
- VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma (PHASE3)
- Chia Seeds Consumption in Hypertriglyceridemia (NA)
- Effect of Antioxidant Docosahexaenoic Acid (DHA) in Cystic Fibrosis Patients (NA)
- Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis (PHASE3)
- DHA and Vitamin D in Children With Biopsy-proven NAFLD (PHASE3)
- Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer (PHASE4)
- Effects of EPA and Vitamin E on Leptin, Adiponectin and Enzymatic Antioxidants in Type 2 DM (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- placebo pearls CI brief — competitive landscape report
- placebo pearls updates RSS · CI watch RSS
- Bambino Gesù Hospital and Research Institute portfolio CI